当前位置：首页 > 文献互助 > 互助详情

期刊论文One Pivotal Trial, the New Default Option for FDA Approval — Ending the Two-Trial Dogma复制

用户6X7Ch8WUQ_gI 1小时前 10 已完结

1. 当前求助状态已完结, 请及时下载应助文件

2. 系统将在 2026-03-04 09:59:51 删除文件

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

其他信息:

出版社: Massachusetts Medical Society
作者: Vinay Prasad; Martin A. Makary

互助时间线

楼主确认了用户0osVRilhgf1q应助的文件是正确的, 求助状态变成已完结

用户0osVRilhgf1q上传了文件(pdf 312.10 KB), 求助状态变成待确认

Identification and Root Cause Analysis of the Visible Particles Commonly Encountered in the Biopharmaceutical Industry 7分钟前

Lycium barbarum polysaccharides promoted proliferation and differentiation in osteoblasts 26分钟前

{Start Here}[New and Changed] Dextrose 37分钟前

Recent Advances in Transition-Metal-Catalyzed Synthetic Transformations of Organosilicon Reagents 46分钟前

中国骨关节炎诊疗指南（2024版） 57分钟前

[Intralesional therapy using recombinant interferon alpha 2 B in lesions of the uterine cervix caused by human papilloma virus] 1小时前

Factors Contributing to the Nonlinear Pharmacokinetics of Astegolimab: A Close Examination of Potential Causes 1小时前

One Pivotal Trial, the New Default Option for FDA Approval — Ending the Two-Trial Dogma 1小时前

Preoptic Neural Circuitry for Dramatic and Gentle Thermoregulation 1小时前

Bioorthogonal chemistry for prodrug activation in vivo 1小时前